Experiences with the Homozygous Cases of Familial Hypercholesterolemia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lebanese are at particular high risk for familial hypercholesterolemia, a combined result of founder mutations and high incidence of consanguinity [23,24].”
From Dementia prevalence, care arrangement and access to care in Lebanon: a pilot study (2017) · cites this paper as [24]
In the citing paper
“In line with this, loss-of-function LDLR mutations are associated with elevated plasma LDL levels and cardiovascular risk.11–13”
From (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis (2018) · cites this paper as [12]
Citations
Cites
The inheritance of essential familial hypercholesterolemia
Khachadurian, A. K. (1964) · The American Journal of Medicine · doi:10.1016/0002-9343(64)90196-2 · Cited by 280
Self-citationThe inheritance of familial hypercholesterolemia
Jensen, J., & Blankenhorn, D. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90041-1 · Cited by 95
Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia)
Khachadurian, A. K. (1968) · Arthritis & Rheumatism · doi:10.1002/art.1780110303 · Cited by 78
Self-citationKhachadurian, A. K., & Demirjian, Z. N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80091-2 · Cited by 51
Self-citation
Cited by
Items 101–185 of 185
Faiz, F., Hooper, A. J., & BOCKXMEER, F. M. V. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.646942 · Cited by 24
Autosomal recessive hypercholesterolemia in Spanish kindred due to a large deletion in the ARH gene
Quagliarini, F., Vallvé, J.-C., Campagna, F., Álvaro, A., Fuentes, F. J., Sirinian, M. I., Meloni, F., Masana, L., & Arca, M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.06.012 · Cited by 22
Moderate phenotypic expression of familial hypercholesterolemia in Tunisia
Jelassi, A., Slimani, A., Jguirim, I., Najah, M., Abid, A., Boughamoura, L., Mzid, J., Feki, M., Maatouk, F., Rouis, M., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.008 · Cited by 20
“Their mean life expectancy was 13 years old compared with 17 years old in Japan [13] and 21 years old in Lebanon [14].”
BackgroundResultInfluentialGene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
Kassim, S. H., Wilson, J. M., & Rader, D. J. (2010) · Clinical Lipidology · doi:10.2217/clp.10.73 · Cited by 20
A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia
Canizales‐Quinteros, S., Aguilar-Salinas, C. A., Huertas‐Vázquez, A., Ordóñez-Sánchez, M. L., Rodríguez-Torres, M., Ventura-Gallegos, J. L., Riba, L., Ramírez-Jiménez, S., Salas-Montiel, R., Medina-Palacios, G., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1192-9 · Cited by 21
“Among them, an autosomal recessive form of familial hypercholesterolemia [ARH (MIM603813)] is characterized by clinical symptoms and plasma cholesterol levels intermediate between those found in heterozygous and homozygous familial hypercholesterolemia (FH) individuals (Khachadurian and Uthman 1973; Zuliani et al. 199…”
BackgroundA boy with autosomal recessive hypercholesterolaemia.
Rodenburg, J., Wiegman, A., Vissers, M. N., Kastelein, J. J. P., & Stalenhoef, A. F. H. (2004) · PubMed · Cited by 20
Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses
de Jong, J. G. Y., van Gent, C. M., & Delleman, J. W. (1976) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(76)80021-2 · Cited by 20
Fellin, R., Zuliani, G., Arca, M., Pintus, P., Pacifico, A., Montali, A., Corsini, A., & Maioli, M. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80032-7 · Cited by 18
Khachadurian, A. K., Lipson, M., & Kawahara, F. S. (1975) · Atherosclerosis · doi:10.1016/0021-9150(75)90083-0 · Cited by 18
Self-citationBlood rheology and fibrinogen in children with familial hypercholesterolaemia
Jay, R. H., McCarthy, S., RAMPLING, M. W., & Betteridge, D. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90193-7 · Cited by 16
Pseudohomozygous and Pseudoheterozygous Type II Hyperlipoproteinemia
Mishkel, M. A. (1976) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1976.02120100081013 · Cited by 15
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort
Garg, A., Fazio, S., Duell, P. B., Baass, A. W., Udata, C., Joh, T., Riel, T., Sirota, M., Dettling, D. E., Hong, L., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz015 · Cited by 17
Patsch, W., Patsch, J. R., & Gotto, A. M. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30643-5 · Cited by 23
Berkman, N., Weir, B. S., Schwartz, S., Reshef, A., & Leitersdorf, E. (1992) · Human Genetics · doi:10.1007/bf00215674 · Cited by 14
“Population studies have revealed that several genetically isolated communities have an increased prevalence of FH (Seftel et al. 1980; Khachadurian and Uthman 1973; Moorjani et al. 1989).”
BackgroundThe vascular pathology of familial hypercholesterolemia
Stehbens, W. E., & Martin, M. (1991) · Pathology · doi:10.3109/00313029109061441 · Cited by 13
Keller, C., Spengel, F. A., Wieczorek, A. J., Wolfram, G., & llner, N. Z. O. (1981) · Annals of Nutrition and Metabolism · doi:10.1159/000176481 · Cited by 13
The Lipid Hypothesis: Genetic Basis
Glueck, C. J. (1978) · Archives of Surgery · doi:10.1001/archsurg.1978.01370130037006 · Cited by 12
Suryawanshi, Y. N., & Warbhe, R. A. (2023) · Cureus · doi:10.7759/cureus.49121 · Cited by 19
“Its true mechanism of action is unknown; it may be involved in the interaction of clathrin-coated pits with LDLRs [14].”
BackgroundPatni, N., Ahmad, Z., & Wilson, D. P. (2016) · Europe PMC (PubMed Central) · Cited by 14
Khoury, P. E., Couvert, P., Elbitar, S., Ghaleb, Y., Khalil, Y. A., Azar, Y., Ayoub, C., Superville, A., Guérin, M., Rabès, J., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.08.013 · Cited by 13
Nikasa, P., Tricot, T., Mahdieh, N., Baharvand, H., Totonchi, M., Hejazi, M. S., & Verfaillie, C. M. (2021) · Stem Cells and Development · doi:10.1089/scd.2020.0199 · Cited by 12
Reshef, A., Meiner, V., Dann, E. J., Granat, M., & Leitersdorf, E. (1992) · Human Genetics · doi:10.1007/bf00217130 · Cited by 11
“Khachadurian and Uthman (1973) observed an increased prevalence of FH in Lebanon.”
BackgroundNAKAJIMA, T., Nakamura, T., Funahashi, T., Kanai, H., Kurata, Y., Matsuzawa, Y., & Tarui, S. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90035-4 · Cited by 11
Halpern, M. J. (1995) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(95)00004-6 · Cited by 13
Mechanisms of adverse effects during hemapheresis
Strauss, R. G. (1996) · Journal of Clinical Apheresis · doi:10.1002/(sici)1098-1101(1996)11:3<160::aid-jca7>3.0.co;2-9 · Cited by 59
Arcus lipoides corneae und Hyperlipoprotein�mie
Parwaresch, M. R., Haacke, H., M�der, C., & Godt, C. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01469052 · Cited by 10
Hypercholesterolemia in Childhood
West, R. J., & Lloyd, J. K. (1979) · Advances in Pediatrics · doi:10.1016/s0065-3101(22)00669-7 · Cited by 10
Assessing the genetic burden of familial hypercholesterolemia in a large middle eastern biobank
Gandhi, G. D., Aamer, W., Krishnamoorthy, N., Syed, N., ALIYEV, E. E., Al-Maraghi, A., Kohailan, M., Alenbawi, J., Elanbari, M., Mifsud, B., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03697-w · Cited by 12
McGowan, M. P., Moriarty, P. M., & Backes, J. M. (2014) · Clinical Lipidology · doi:10.2217/clp.14.43 · Cited by 8
Shirahama, R., Ono, T., Nagamatsu, S., Sueta, D., Takashio, S., Chitose, T., Fujisue, K., Sakamoto, K., Yamamoto, E., Izumiya, Y., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.1060-18 · Cited by 9
“reported on families with a background of genetically dominant hypercholesterolemia and on those with recessive inheritance (18).”
BackgroundDrug therapy of hyperlipidemia
Prihoda, J. S., & Illingworth, D. R. (1992) · Current Problems in Cardiology · doi:10.1016/0146-2806(92)90004-8 · Cited by 7
Genetic Defenses against Hypercholesterolemia
Hobbs, H. H., Graf, G. A., Yu, L., Wilund, K. R., & Cohen, J. C. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.499 · Cited by 7
As bases moleculares das hipercolesterolemias familiares no Brasil: o Rio Grande do Sul
Werutsky, C. A. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2006.tde-01082007-105409 · Cited by 8
Komuro, I., Kato, H., Nakagawa, T., Takahashi, K., Mimori, A., Takeuchi, F., Nishida, Y., & Miyamoto, T. (1987) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198711000-00008 · Cited by 6
Autoimmune haemolysis as an unusual cause of anaemia in von Recklinghausen's disease.
Tekın, F., Özütemiz, Ö., Carcurgan, S., & İlter, T. (2004) · PubMed · Cited by 6
Prenatal Diagnosis of Hereditary Biochemical Disorders of Metabolism
Milunsky, A. (1979) · Springer eBooks · doi:10.1007/978-1-4684-3438-5_7 · Cited by 6
Role of conflict of interest in scientific objectivity: A case of a Nobel Prize work
Shamoo, A. E. (1992) · Accountability in Research · doi:10.1080/08989629208573805 · Cited by 5
Extracardiale Atherosklerose bei Patienten mit famili�rer Hypercholesterin�mie
Keller, C., Seidl, O., Wolfram, G., & Z�llner, N. (1983) · Journal of Molecular Medicine · doi:10.1007/bf01530839 · Cited by 5
“Khachadurian [16] beobachtete bei 52 homozygoten Patienten keine Symptome einer extracardialen Atherosklerose.”
BackgroundOcular manifestations of severe familial hypercholesterolemia
Ghannam, A. B., Istambouli, R., Hamam, M. S., Chalhoub, J. M., Fahed, A. C., & Hamam, R. N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30487 · Cited by 4
“Patients exhibit external manifestations such as tendinous xanthomas, xanthelasmas, corneal arcus, and an accelerated onset of atherosclerosis and premature cardiovascular disease [1,4].”
BackgroundGenetic diagnosis of familial hypercholesterolemia in affected relatives using pedigree tracing
Hsia, S. H., Connelly, P. W., & Hegele, R. A. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(96)00017-3 · Cited by 4
Kaloustian, V. M. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_13 · Cited by 5
Cholesterol (and cardiovascular risk) in adolescence
Kohn, M. R., & Jacobson, M. S. (2004) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000133629.49167.3f · Cited by 7
Low-molecular-weight heparin to prevent pre-eclampsia: there is no evidence and potential harm.
Middeldorp, S. (2004) · PubMed · Cited by 6
van Heyningen, C. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411422652 · Cited by 3
Gunther, S. F., Gunther, A. G., Hoeg, J. M., & Kruth, H. S. (1986) · The Journal Of Hand Surgery · doi:10.1016/s0363-5023(86)80208-8 · Cited by 2
Familial hyperlipidaemia in Malaysian children.
Kl, K., Tan, H., & Ym, L. (2000) · PubMed · Cited by 2
Melnik, B. C. (2012) · Springer eBooks · doi:10.1007/978-3-642-24163-5_89 · Cited by 2
Harada‐Shiba, M., Tajima, S., & Yamamoto, A. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05431-h · Cited by 2
[Prognostic significance of serum immunoglobulin paraprotein in chronic lymphocytic leukemia].
Yang, S., Zou, Z., Li, Y., Zhang, L., Han, T., Fan, L., Xu, W., & Li, J. (2012) · PubMed · Cited by 2
Familial hypercholesterolemia: Diagnosis, metabolic defect and management
Jackson, R. L., Smith, L. C., Taunton, O. D., & Gotto, A. M. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90192-8 · Cited by 2
Melnik, B. C. (2022) · Springer eBooks · doi:10.1007/978-3-662-63709-8_89 · Cited by 2
Inclisiran in Dyslipidemia with High Residual Platelet Reactivity
Kapsultanova, D. A., Жангелова, Ш. Б., Nurmukhammad, F., Makasheva, Z., Sakhov, O., Tamara, G., Rustamova, F., Akhmentayeva, D., & Aubakirova, B. (2026) · Diseases · doi:10.3390/diseases14010030 · Cited by 1
“Extremely high levels of fibrinogen, a primary clotting factor and risk factor for coronary heart disease (CHD) [53], are found in homozygous FH individuals, who have a high incidence of early CHD-related mortality [54].”
McDermott, D. A., Ganesh, S. K., Herrington, D. M., Hong, Y., Jaquish, C. E., Arnett, D. K., Baird, A. E., Barkley, R. A., & Basson, C. T. (2007) · Cited by 1
Genetic Disorders of Lipoprotein Metabolism
Brown, A. S., Dababneh, E. G., Chaus, A. M., Chyzhyk, V., Marinescu, V., & Pyslar, N. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_3 · Cited by 2
Rare monogenic disorders of cholesterol metabolism
Bednarska‐Makaruk, M., & Ługowska, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00024-9 · Cited by 4
Endocytosis of Cargo Proteins: LDL
Traub, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30024-4 · Cited by 1
Monogenic Hypercholesterolemia: Genetics
Day, I. N. M. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0005940.pub2 · Cited by 1
Rodenburg, J. (2005) · UvA-DARE (University of Amsterdam) · Cited by 1
Chapter 18. Disorders of Lipid Metabolism
Holland, G. F., & Pereira, J. N. (1974) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61439-6 · Cited by 1
Stein, E. A., & Black, D. M. (1990) · Springer eBooks · doi:10.1007/978-3-662-02613-7_29 · Cited by 1
Kim, S., KUTSUMI, Y., NAKAI, T., & MIYABO, S. (1991) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.55.68
Coronary heart disease risk profiles in children with heterozygous familial hypercholesterolemia
ANDERSEN, G. E. (1983) · Preventive Medicine · doi:10.1016/0091-7435(83)90261-x
Xanthomatose cutanéo-tendineuse, atteinte valvulaire mitro-aortique et coronaire
Dezellus, P., Guérinon, J., Vuong, N. P., Camilleri, J.-P., Mostefai, M., & Maurice, P. (1985) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(85)80100-4
Rheologic, haemostatic, and coagulative variables in type II hyperlipoproteinemic subjects
Bo, M., Molaschi, M., Neirotti, M., Fonte, G., Pernigotti, L. M., Bonino, F., Gottero, M., & Fabris, F. M. (1994) · International Journal of Angiology · doi:10.1007/bf02014938
Autosomal recessive hypercholesterolemia and bilio-pancreatic diversion: A case report
Narwaria, M., & Khiria, L. S. (2010) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2009.11.002
Cardiac Surgery in Homozygous Familial Hypercholesterolemia
Kawamura, T., Mogi, K., Enomoto, Y., Sakurai, M., Matsuura, K., & Takahara, Y. (2013) · Japanese Journal of Cardiovascular Surgery · doi:10.4326/jjcvs.42.307
Genetics of the Hyperlipidemias and Cardiovascular Implications
Kwiterovich, P. O. (1977) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-4220-5_115
Carotid Atherogenesis: From Experimental Models to Humans
Orlandi, A. (2008) · CRC Press eBooks · doi:10.3109/9780203091548-7
Lipoproteinkonstellation bei Patienten verschiedener Altersgruppen mit Arcus lipoides corneae
Haacke, H., Parwaresch, M. R., & Rossée, H. (1979) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-85454-5_117
Melnik, B. C. (2020) · Springer eBooks · doi:10.1007/978-3-662-58713-3_89-1
Monogenic Hypercholesterolemia
McPherson, R. (2007) · Wiley eBooks · doi:10.1002/9780470691977.ch2
(1988) · Journal of the Royal Society of Medicine · doi:10.1177/014107688808100629
Monogenic Hypercholesterolemias
Civeira, F., & Pocoví, M. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_10
Melnik, B. C. (2009) · Springer eBooks · doi:10.1007/978-3-540-29316-3_83
Melnik, B. C. (2018) · Springer eBooks · doi:10.1007/978-3-662-49544-5_89
Melnik, B. C. (2016) · Springer eBooks · doi:10.1007/978-3-662-49546-9_89-1
Orlandi, A. (2008) · CRC Press eBooks · doi:10.3109/9780203091548-3
Murakami, T. (2011) · Springer eBooks · doi:10.1007/springerreference_33738
In silico Analysis of a Nonsense Mutation Linked to Autosomal Recessive Hypercholesterolemia Type 4
Gardner, C., & Good, D. J. (2025) · American Journal of Undergraduate Research · doi:10.33697/ajur.2025.132
Genetic Dyslipoproteinemias Associated with Coronary Atherosclerosis
Lee, J., & Burns, T. L. (1987) · Springer eBooks · doi:10.1007/978-1-4613-2305-1_9
Gandhi, G. D., Aamer, W., Krishnamoorthy, N., Syed, N., ALIYEV, E. E., Al-Maraghi, A., Kohailan, M., Alenbawi, J., Elanbari, M., Mifsud, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21500707
Martínez‐Hervás, S., & Ascaso, J. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-44-313825-6.00329-0
Hypercholestérolémie familiale : recherche de nouveaux gènes et étude des formes polygéniques
Ghaleb, Y. (2017) · theses.fr (ABES) · doi:10.70675/ab0b16eez4c40z4cb7zb42fzb7740e0c98ea
Metadata
- Authors
- Khachadurian, A. K., & Uthman, S. M.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Khachadurian, A.K.
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 1973
- Volume
- 15
- Issue
- 1-2
- Pages
- 132-140
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W2025664844
- Cited by
- 185
- References
- 4
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 8
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Annals of Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- familial hypercholesterolemia, homozygous familial hypercholesterolemia, hypercholesterolemia, lipid metabolism disorders
- MeSH terms
- Adolescent, Adult, Blood Protein Disorders, Child, Child, Preschool, Cholesterol, Cholestyramine Resin, Female, Homozygote, Humans, Hypercholesterolemia, Lipids, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Male, Nicotinic Acids, Xanthomatosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.